Similarly, preclinical studies have demonstrated that the combination of MYC inhibition with radiotherapy can significantly enhance tumor radiosensitivity and reduce radioresistance, suggesting potential improvements in local tumor control (Wang et al., 2022). The gene discussed is MYC; the disease is neoplasm.